Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome

NCT02398604 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Study was closed due to Sponsor switched to Longeveron. New Identifier is NTC03525418

Conditions

Hypoplastic Left Heart Syndrome

Interventions

DRUG: Allo-hMSCs
DRUG: Placebo

Sponsor

Longeveron Inc.